Thanks! You've successfully subscribed to the BONEZONE®/OMTEC® Monthly eNewsletter!

Please take a moment to tell us more about yourself and help us keep unwanted emails out of your inbox.

Choose one or more mailing lists:
BONEZONE/OMTEC Monthly eNewsletter
OMTEC Conference Updates
Advertising/Sponsorship Opportunities
Exhibiting Opportunities
* Indicates a required field.

3D Systems and Antleron Partner on Biomedical 3D Printing

3D Systems and Antleron seek to advance and accelerate the development of regenerative products and personalized patient care using 3D bioprinting technologies.

Antleron's R&D facility in Leuven, Belgium is an incubator for medical and life science innovation. Its "living therapy factory" merges cells, biomaterials, biologics, bioreactors and 3D Systems printers to engineer living therapies. One of Antleron's projects is Prosperos, EU-funded research into "smart“ 3D printed implants to repair large bone defects that is focused on the development of biologically active implants that can be tailor-made to fit the needs of individual patients. Upon successful implementation, the implants offer faster patient recovery and a reduction in revision surgeries.

The 3D Systems/Antleron relationship will employ 3D Systems’ ProJet® MJP 2500 and Figure 4® 3D printers and portfolio of 21 biocompatible materials; 3D Sprint® and 3DXpert® software, and post-processing equipment and processes. The partners seek to establish a flexible, scalable Digital Factory approach that can lead to new ways to manufacture functionalized medical implants, vaccines, cell therapies and living tissues.

Antleron CEO Jan Schrooten said, “The vision of Antleron is to sustainably bring living therapies into the clinic. 3D printing is key to this endeavor, and we are eager to collaborate with 3D Systems and its experts. I look forward to the pioneering solutions we’ll be able to achieve to elevate the efficacy of bioprinting and extend its biomedical application reach.”

“3D Systems is excited about working with Antleron as they explore bioprinting, and especially their capability to develop end-to-end solutions utilizing the 3D Systems’ state of the art printing platforms and materials,” said Chuck Hull, co-founder and CTO for 3D Systems. “As we look to the future, bioprinting and regenerative medicine are large opportunities for 3D printing, and we look forward to expanding the role 3D Systems will play in these exciting fields.”